Check out our most popular compounded medications! Get Started
The Urea 8%/Mupirocin 0.8%/Clobetasol Propionate 0.005%/Nystatin 30,000 U/Gm Topical Ointment from Bayview Pharmacy is a semi-solid formulation for external skin application. Dispensed in a tube, it provides a greasy base to aid in the delivery of therapeutic agents for localized treatment. It is typically used for treating skin conditions such as impetigo, folliculitis, dermatitis, tinea versicolor, and psoriasis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Urea 8%/Mupirocin 0.8%/Clobetasol Propionate 0.005%/Nystatin 30,000 U/Gm Topical Ointment is a comprehensive compounded formulation designed to address a range of skin conditions. This semi-solid formulation, dispensed in a tube, is designed for external application to the skin. It provides a greasy or oily base that aids in the delivery of medication or therapeutic agents for localized treatment.
The formulation contains Urea, a keratolytic agent that helps to soften and break down thickened skin. Mupirocin, an antibiotic in the formulation, aids in reducing bacterial infections. Clobetasol Propionate, a potent corticosteroid, helps to reduce inflammation and itching. Nystatin, an antifungal agent, assists in treating fungal infections. This combination of medications can be used to treat a variety of skin conditions, including eczema, psoriasis, dermatitis, and fungal infections.
This topical ointment should be applied to the affected area twice daily, or as directed by a healthcare provider. It's important to note that this medication may cause skin irritation, burning, or stinging. If any of these side effects occur, patients should contact their healthcare provider immediately.
If you have any questions about this formulation, please do not hesitate to reach out to us. We are here to assist you with your healthcare needs.
This compounded formulation of Urea 8%/Mupirocin 0.8%/Clobetasol Propionate 0.005%/Nystatin 30,000 U/Gm Topical Ointment is a semi-solid preparation designed for external application to the skin. It is typically used for the treatment of various skin conditions such as atopic dermatitis, seborrheic dermatitis, psoriasis, contact dermatitis, and fungal infections.
The formulation contains Urea, a keratolytic agent that helps to soften and break down thickened skin. Mupirocin, an antibiotic in the formulation, aids in reducing bacterial infections. Clobetasol Propionate, a potent topical corticosteroid, helps to reduce inflammation and itching. Nystatin, an antifungal agent, assists in treating fungal infections.
The ointment should be applied to the affected area twice daily or as directed by a healthcare provider. It is important to note that this formulation should not be used for longer than two weeks, as it may cause skin irritation and thinning. Potential side effects may include burning, stinging, or redness at the application site.
Patients should also be aware of potential drug interactions with this formulation. Urea may interact with other topical medications, such as topical corticosteroids, and should not be used concurrently. Mupirocin may interact with other antibiotics, and should not be used concurrently. Clobetasol Propionate may interact with other topical corticosteroids, and should not be used concurrently. Nystatin may interact with other antifungal medications, and should not be used concurrently.
If you have any questions about this formulation or its potential interactions, please consult with your healthcare provider or pharmacist.
Urea 8%/Mupirocin 0.8%/Clobetasol Propionate 0.005%/Nystatin 30,000 U/Gm Topical Ointment is a compounded formulation designed to address a range of skin conditions. This semi-solid formulation is dispensed in a tube and is intended for external application to the skin. The greasy or oily base of the ointment aids in the delivery of the medication, providing localized treatment.
The ointment contains four active ingredients: Urea, Mupirocin, Clobetasol Propionate, and Nystatin. Urea is a keratolytic agent that softens and breaks down thick, scaly skin. Mupirocin is an antibiotic that inhibits the growth of bacteria on the skin. Clobetasol Propionate is a corticosteroid that reduces inflammation and itching. Nystatin is an antifungal agent that inhibits the growth of fungi on the skin.
This topical ointment is used to treat a variety of skin conditions, including eczema, psoriasis, seborrheic dermatitis, and fungal infections. It is applied directly to the affected area of the skin as directed by a healthcare provider. It is crucial to follow the instructions on the label and to use the ointment for the full course of treatment, even if the symptoms improve.
If you have any questions about using Urea 8%/Mupirocin 0.8%/Clobetasol Propionate 0.005%/Nystatin 30,000 U/Gm Topical Ointment, please consult with your healthcare provider. They can provide the most accurate and personalized advice based on your specific skin condition and overall health status.
This formulation is designed for external application to the skin to treat conditions such as skin inflammation, infections, or aid in wound healing. The different components work together to provide a comprehensive treatment.
This ointment should be applied topically to the affected area as directed by your healthcare provider. It is not intended for oral, ophthalmic, or intravaginal use.
Urea helps to hydrate and soften the skin. Mupirocin is an antibiotic that prevents bacteria from growing on your skin. Clobetasol Propionate is a corticosteroid that reduces swelling, itching, and redness. Nystatin is an antifungal medication that prevents fungus from growing on your skin.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not apply extra doses unless directed by your healthcare provider.
Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or breastfeeding. The effects on the fetus or infant are not fully known.
Common side effects may include burning, itching, irritation, redness, or dryness of the skin. If these persist or worsen, contact your healthcare provider immediately.
Unless directed by your healthcare provider, this ointment should not be used on the face, underarms, or groin area due to the sensitive nature of the skin in these areas.
Do not cover the treated area with a bandage or dressing unless instructed by your healthcare provider as this can increase absorption of the medication and lead to unwanted side effects.
If the ointment accidentally gets into your eyes, rinse thoroughly with water and contact your healthcare provider if irritation persists.
Before using other skincare products, consult with your healthcare provider as they may interfere with the effectiveness of the ointment or cause additional irritation.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
